全文获取类型
收费全文 | 4856篇 |
免费 | 301篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 89篇 |
妇产科学 | 133篇 |
基础医学 | 700篇 |
口腔科学 | 172篇 |
临床医学 | 362篇 |
内科学 | 1122篇 |
皮肤病学 | 126篇 |
神经病学 | 381篇 |
特种医学 | 165篇 |
外科学 | 668篇 |
综合类 | 47篇 |
预防医学 | 252篇 |
眼科学 | 64篇 |
药学 | 399篇 |
中国医学 | 10篇 |
肿瘤学 | 446篇 |
出版年
2023年 | 34篇 |
2022年 | 67篇 |
2021年 | 118篇 |
2020年 | 68篇 |
2019年 | 93篇 |
2018年 | 102篇 |
2017年 | 85篇 |
2016年 | 111篇 |
2015年 | 103篇 |
2014年 | 140篇 |
2013年 | 175篇 |
2012年 | 323篇 |
2011年 | 289篇 |
2010年 | 159篇 |
2009年 | 139篇 |
2008年 | 260篇 |
2007年 | 280篇 |
2006年 | 249篇 |
2005年 | 277篇 |
2004年 | 238篇 |
2003年 | 220篇 |
2002年 | 217篇 |
2001年 | 101篇 |
2000年 | 107篇 |
1999年 | 92篇 |
1998年 | 41篇 |
1997年 | 25篇 |
1996年 | 32篇 |
1994年 | 20篇 |
1993年 | 18篇 |
1992年 | 61篇 |
1991年 | 72篇 |
1990年 | 53篇 |
1989年 | 83篇 |
1988年 | 68篇 |
1987年 | 69篇 |
1986年 | 69篇 |
1985年 | 52篇 |
1984年 | 37篇 |
1983年 | 37篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 41篇 |
1978年 | 24篇 |
1977年 | 22篇 |
1974年 | 19篇 |
1972年 | 18篇 |
1969年 | 26篇 |
1968年 | 29篇 |
1966年 | 27篇 |
排序方式: 共有5175条查询结果,搜索用时 15 毫秒
41.
N Aya K Yoshioka K Murakami S Hino K Okada O Matsuo S Maki 《The Journal of pathology》1992,166(3):289-295
We carried out an immunohistochemical study of tissue-type plasminogen activator (PA) and urokinase-type PA, and their inhibitors, PA inhibitor-1 and PA inhibitor-2, using renal biopsy specimens obtained from 86 patients with various forms of glomerulonephritis. The controls were four normal renal tissue specimens. On immunofluorescent observation, granular staining for tissue-type PA was found to be distributed along the glomerular capillary walls. The fluorescence was weak in the normal renal tissue and occasionally intense in the tissues of patients with IgA nephritis, minimal change nephrotic syndrome, and lupus nephritis. PA inhibitor-1 was abundant in the glomerular epithelial cells and scarce in the mesangial area and glomerular capillary lumens of the normal renal tissues. This was confirmed by immunoelectron microscopy using gold staining. The fluorescence of PA inhibitor-1 was weaker in some specimens of nephritic tissues than in the normal renal tissues. Urokinase-type PA and PA inhibitor-2 were negative within the glomeruli in all the specimens. In the glomerulonephritic tissues which were fibrin deposition-positive, tissue-type PA expression in the glomeruli tended to be strong. An association between fibrin deposition and PA inhibitor-1 staining was not clear. These data suggest that expression of tissue-type PA in the glomeruli increases in association with fibrin deposition. 相似文献
42.
43.
T Saijo H Makino S Tamura H Kuriki Y Ashida S Terao Y Maki 《International archives of allergy and applied immunology》1986,79(3):231-237
Amoxanox has potent antiallergic activity because it inhibits the release of chemical mediators such as histamine and leukotrienes. We studied the in vitro effect of amoxanox on arachidonic acid metabolism, including the lipoxygenase and cyclooxygenase pathways. Amoxanox inhibited calcium ionophore A23187-induced formation of 5-HETE, LTB4, SRS-A (LTC4, LTD4 and LTE4), and 12-HETE in rat peritoneal resident monocytes. These results indicate that amoxanox inhibits 5- and 12-lipoxygenases. The compound, however, did not affect the formation of TXB2 or 6-keto-PGF1 alpha in guinea pig lung fragments and PGE2 or PGF2 alpha in bovine seminal vesicles, suggesting that it did not inhibit cyclooxygenase. These results show that the antiallergic action of amoxanox is associated, at least in part, with the reduction of leukotrienes due to the inhibition of lipoxygenases. 相似文献
44.
Maki Yoshikawa Masashi Hosokawa Kazuo Miyashita Hoyoku Nishino Takeshi Hashimoto 《Nutrients》2021,13(4)
Fucoxanthin (Fx) has preventive effect against muscle atrophy and myotube loss in vitro, but it has not yet been examined in vivo. Therefore, we aimed to investigate the effect of Fx on dexamethasone (Dex)-induced muscle atrophy and fat mass in mice. ICR mice were fed with Fx diets from 2 weeks before Dex treatment to the end of the study. Muscle atrophy was induced in the mice by oral administration of Dex. Body weight was significantly lower by Dex treatment. Visceral fat mass in the Fx-treated group were significantly lower than those in the control group. The Dex-induced decrease in tibialis anterior muscle mass was ameliorated by Fx treatment. Fx treatment significantly attenuated muscle lipid peroxidation compared with the control and Dex-treated groups. The phosphorylation of AMPK was significantly higher in the Dex-treated group than in the control group. The expression of cytochrome c oxidase (COX) IV was significantly higher in the Fx-treated group than in the control group. These results suggest that Fx may be a beneficial material to prevent muscle atrophy in vivo, in addition to the effect of fat loss. 相似文献
45.
46.
Yoshida M Abe O Uchino J Kikuchi K Abe R Enomoto K Tominaga T Fukami A Sakai K Koyama H Sugimachi K Nomura Y Hattori T Ogawa N 《Breast cancer (Tokyo, Japan)》1997,4(2):103-113
A multi-center, randomized controlled collaborative study was conducted in 310 institutions located throughout Japan for 3 years and 9 months from February 1985 until October 1988 to evaluate the efficacy of post-operative adjuvant therapy for patients who had previously undergone curative surgery for treatment of Stage IIIa breast cancer. Patients with estrogen receptor-positive [ER( + )] breast cancer were treated with two types of regimens, ie, cyclophosphamide + adriamycin + fluorouracil (CAF; 2 cycles) + Futraful (FT) or CAF (2 cycles) + FT + tamoxifen (TAM), and the clinical benefit of additional use of TAM was evaluated. Of the 509 ER( + ) patients registered for the trial, 473 patients (92.9%) were eligible for evaluation. The 5-year survival rate was 77.2% for the CAF + FT group and 74.6% for the CAF + FT+TAM group, and the 5-year disease-free survival rate was 56.7% for the CAF+FT group and 59.2% for the CAF + FT + TAM group. Neither the survival rate nor the disease-free survival rate differed significantly between the groups. Analyses by factor revealed that the 5-year disease-free rate for lymph node-negative patients in the CAF + FT + TAM group was significantly higher than that for the corresponding patients in the CAF + FT group. No differences were noted in the incidence of adverse reactions between the two treatment groups, other than an increase in LDH (the frequency of which was higher in the CAF + FT+TAM group than in the CAF + FT group). Patients with estrogen receptor-negative [ER( -)] breast cancer were treated with two types of regimens, ie, CAF + FT or CAF + FT + adriamycin (ADR), and the clinical benefit of the combined use of intermittent doses of ADR was evaluated. Of the 514 ER(-) patients registered in the trial, 478 (93.0%) were eligible for evaluation. The 5-year survival rate was 64.9% for the CAF + FT group and 63.0% for the CAF + FT + ADR group, and the 5-year disease-free survival rate was 59.2% for both CAF + FT and CAF + FT + ADR groups. Neither the survival rate nor the disease-free survival rate differed significantly between the groups. There were no significant differences between these groups in analyses by nodal or menopausal status. The incidences of adverse reactions including anorexia, nausea/vomiting and alopecia were higher in the CAF + FT+ADR group than in the CAF + FT group. 相似文献
47.
Two cases of lymphangiomatosis of bone, a very rare systemic condition characterized by both skeletal and parenchymal lesions, are presented. The skeletal changes have an appearance similar to haemangiomas in the spine, and soap-bubbly lesions in the flat bones. One case carried the diagnosis of eosinophilic granuloma for 18 years. The findings on MRI, which have not been previously well-established, are discussed. 相似文献
48.
Endovascular treatment of ruptured dissecting aneurysms aimed at occlusion of the dissected site by using Guglielmi detachable coils 总被引:13,自引:0,他引:13
Yamaura I Tani E Yokota M Nakano A Fukami M Kaba K Matsumoto T 《Journal of neurosurgery》1999,90(5):853-856
OBJECT: Surgical or endovascular occlusion of the parent artery proximal to an aneurysm has been recommended for treatment of dissecting aneurysms of the intracranial posterior circulation. However, dissecting aneurysms may rupture even after proximal occlusion because distal progression of thrombus is necessary to occlude the dissecting aneurysm completely, and this may be delayed by the presence of retrograde flow. In this article the authors present their experience in treating six patients with ruptured dissecting aneurysms. METHODS: The authors report on six patients with a ruptured dissecting aneurysm in the posterior fossa who were successfully treated by endovascular occlusion of the aneurysm by using Guglielmi detachable coils. The procedure was particularly aimed at occluding the dissected site. CONCLUSIONS: At the present time, endovascular occlusion of the dissected site is a safe, minimally invasive, and reliable treatment for dissecting aneurysms when a test occlusion is tolerated and adequate collateral circulation is present. 相似文献
49.
50.